Reading a regulatory notice rather than an article about it — what changed since

Reading a regulatory notice rather than an article about it — what changed since — setting out what I have, and where I think it stops being reliable.

A logistics question, since the answers here are usually better than anywhere else I have looked.

Parcel despatched 6 days ago, tracking last updated 6 days ago at a customs facility, no further movement. Cold pack included at despatch.

Two questions. First, at what point is this genuinely a problem rather than an ordinary delay? Second, if it does arrive, what is the actual decision process for assessing it, as opposed to the two extremes people usually offer?

Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal use depends on your country's rules, not on where it is sold.

post #12 is right about the mechanism and I think understates the practical bit.

Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only compounds, which are not approved for any human use.

Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.

On post #23 — agreed on the reasoning, with one qualification.

Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only compounds, which are not approved for any human use.